NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
基本信息
- 批准号:7337024
- 负责人:
- 金额:$ 29.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-11 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:antigen antibody reactionantigen presentationaspergillosiscell migrationcellular immunitychemokinecolorimetryconfocal scanning microscopycytokine receptorsenzyme linked immunosorbent assayflow cytometryhost organism interactionimmunocytochemistryimmunofluorescence techniqueimmunosuppressioninterferon gammalaboratory mousemonocyte chemoattractant protein 1natural killer cellsneutropeniasingle cell analysis
项目摘要
DESCRIPTION (provided by applicant): Invasive pulmonary aspergillosis, a common complication of immunosuppression, carries a strikingly poor outcome despite currently available therapy. While substantial work has evaluated the role of neutrophils in the lung's innate immune response to this pathogen, the role of other effector cells in host defense against this organism is less clear. Natural killer (NK) cells are a subset of lymphocytes important in immune responses against tumor cells, transplanted allogeneic cells, and several classes of micro-organisms. Our preliminary studies indicate that NK cells are critical to host survival in neutropenic mice with invasive aspergillosis and that their recruitment to the lung in the setting of this infection may be mediated by the CC chemokine ligand, MCP-1/CCL2. Moreover, NK cell-derived interferon-gamma (IFN-gamma) appears to augment fungal clearance from the lung. We therefore hypothesize that NK cells are integral components of innate host defense against invasive aspergillosis in neutropenic hosts, and that enhancing the recruitment of NK cells to the lung or augmenting their effector functions will improve the outcome of invasive aspergillosis. We shall address these hypotheses by examining the following Specific Aims in a murine model of invasive pulmonary aspergillosis: 1) To determine the in vitro activity of NK cells against Aspergillus and to determine their in vivo contribution to host defense in invasive aspergillosis; 2) To examine the role of the chemokine ligand, MCP-1/CCL2, and its receptor, CCR2, in the recruitment of NK cells to the lungs in invasive aspergillosis; and 3) To evaluate the role of NK cell-derived IFN-gamma in mediating anti-fungal host defense in vitro and in vivo. We hope that the proposed studies will provide important new insights into the role of NK cells as mediators of innate host defense in the lung in invasive aspergillosis, and that they will also result in development of novel therapies for this devastating infection.
描述(申请人提供):侵袭性肺曲霉菌病,一种常见的免疫抑制并发症,尽管目前有可用的治疗方法,但预后非常差。虽然大量的工作已经评估了中性粒细胞在肺对这种病原体的先天免疫反应中的作用,但其他效应细胞在宿主防御这种生物中的作用还不是很清楚。自然杀伤(NK)细胞是淋巴细胞的一个亚群,在对肿瘤细胞、移植的同种异体细胞和几种微生物的免疫反应中起重要作用。我们的初步研究表明,NK细胞对中性粒细胞减少的侵袭性曲霉病小鼠的宿主生存至关重要,在这种感染的背景下,它们向肺的募集可能是由CC趋化因子配体MCP-1/CCL2介导的。此外,自然杀伤细胞衍生的干扰素-伽马(干扰素-伽马)似乎可以增加肺部真菌的清除。因此,我们假设NK细胞是中性粒细胞减少的宿主抵抗侵袭性曲霉病的天然防御的组成部分,增强NK细胞向肺的募集或增强其效应器功能将改善侵袭性曲霉病的结局。我们将通过检测侵袭性肺曲霉病小鼠模型中的下列特定目标来解决这些假设:1)确定NK细胞在体外对曲霉菌的活性,并确定它们在侵袭性曲霉病中对宿主防御的贡献;2)检测趋化因子配体MCP-1/CCL2及其受体CCR2在侵袭性曲霉病中NK细胞向肺内募集的作用;以及3)评估NK细胞来源的干扰素-γ在体内外介导抗真菌宿主防御中的作用。我们希望拟议的研究将为NK细胞在侵袭性曲霉病中作为肺部天然宿主防御介质的作用提供重要的新见解,并将导致这种毁灭性感染的新疗法的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Borna Mehrad其他文献
Borna Mehrad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Borna Mehrad', 18)}}的其他基金
Neutrophils and adaptive immunity against invasive aspergillosis
中性粒细胞和针对侵袭性曲霉病的适应性免疫
- 批准号:
8996132 - 财政年份:2015
- 资助金额:
$ 29.59万 - 项目类别:
NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
- 批准号:
7654277 - 财政年份:2003
- 资助金额:
$ 29.59万 - 项目类别:
NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
- 批准号:
7849622 - 财政年份:2003
- 资助金额:
$ 29.59万 - 项目类别:
NK cells in host defense against invasive aspergillosis
NK 细胞在宿主防御侵袭性曲霉病中的作用
- 批准号:
6942872 - 财政年份:2003
- 资助金额:
$ 29.59万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 29.59万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 29.59万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 29.59万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 29.59万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 29.59万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 29.59万 - 项目类别: